279 related articles for article (PubMed ID: 26196252)
1. Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?
Zwart W; Terra H; Linn SC; Schagen SB
Nat Rev Clin Oncol; 2015 Oct; 12(10):597-606. PubMed ID: 26196252
[TBL] [Abstract][Full Text] [Related]
2. Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment?
Buwalda B; Schagen SB
Life Sci; 2013 Oct; 93(17):581-8. PubMed ID: 23353876
[TBL] [Abstract][Full Text] [Related]
3. Does endocrine therapy for the treatment and prevention of breast cancer affect memory and cognition?
Jenkins V; Atkins L; Fallowfield L
Eur J Cancer; 2007 Jun; 43(9):1342-7. PubMed ID: 17499988
[TBL] [Abstract][Full Text] [Related]
4. Post-treatment Neurocognition and Psychosocial Care Among Breast Cancer Survivors.
Buchanan ND; Dasari S; Rodriguez JL; Lee Smith J; Hodgson ME; Weinberg CR; Sandler DP
Am J Prev Med; 2015 Dec; 49(6 Suppl 5):S498-508. PubMed ID: 26590645
[TBL] [Abstract][Full Text] [Related]
5. Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial.
Schilder CM; Seynaeve C; Beex LV; Boogerd W; Linn SC; Gundy CM; Huizenga HM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
J Clin Oncol; 2010 Mar; 28(8):1294-300. PubMed ID: 20142601
[TBL] [Abstract][Full Text] [Related]
6. Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies.
Lee PE; Tierney MC; Wu W; Pritchard KI; Rochon PA
Breast Cancer Res Treat; 2016 Aug; 158(3):407-20. PubMed ID: 27432418
[TBL] [Abstract][Full Text] [Related]
7. Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
Psychooncology; 2009 Aug; 18(8):811-21. PubMed ID: 19085975
[TBL] [Abstract][Full Text] [Related]
8. Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients.
Kool M; Fontein DB; Meershoek-Klein Kranenbarg E; Nortier JW; Rutgers EJ; Marang-van de Mheen PJ; van de Velde CJ
Breast; 2015 Jun; 24(3):224-9. PubMed ID: 25704982
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions.
Phillips KA; Bernhard J
J Natl Cancer Inst; 2003 Feb; 95(3):190-7. PubMed ID: 12569140
[TBL] [Abstract][Full Text] [Related]
10. Patterns of change in cognitive function with anastrozole therapy.
Bender CM; Merriman JD; Gentry AL; Ahrendt GM; Berga SL; Brufsky AM; Casillo FE; Dailey MM; Erickson KI; Kratofil FM; McAuliffe PF; Rosenzweig MQ; Ryan CM; Sereika SM
Cancer; 2015 Aug; 121(15):2627-36. PubMed ID: 25906766
[TBL] [Abstract][Full Text] [Related]
11. A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy.
Le Rhun E; Delbeuck X; Lefeuvre-Plesse C; Kramar A; Skrobala E; Pasquier F; Bonneterre J
Breast Cancer Res Treat; 2015 Aug; 152(3):569-80. PubMed ID: 26160250
[TBL] [Abstract][Full Text] [Related]
12. The influence of endocrine treatments for breast cancer on health-related quality of life.
Buijs C; de Vries EG; Mourits MJ; Willemse PH
Cancer Treat Rev; 2008 Nov; 34(7):640-55. PubMed ID: 18514425
[TBL] [Abstract][Full Text] [Related]
13. Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work?
Güth U; Myrick ME; Schötzau A; Kilic N; Schmid SM
Breast Cancer Res Treat; 2011 Oct; 129(3):799-807. PubMed ID: 21750963
[TBL] [Abstract][Full Text] [Related]
14. [Endocrine therapy in breast cancer: efficacy and adverse events].
Odermatt R; Wolfer A; Zaman K
Rev Med Suisse; 2013 May; 9(387):1090-4. PubMed ID: 23757917
[TBL] [Abstract][Full Text] [Related]
15. Cognitive Deficits in Breast Cancer Survivors After Chemotherapy and Hormonal Therapy.
Frank JS; Vance DE; Triebel KL; Meneses KM
J Neurosci Nurs; 2015 Dec; 47(6):302-12. PubMed ID: 26447567
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
17. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.
Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
Psychooncology; 2009 Feb; 18(2):134-43. PubMed ID: 18551510
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Pharmacological and Non-Pharmacological Interventions on Symptom Management and Quality of Life among Breast Cancer Survivors Undergoing Adjuvant Endocrine Therapy: A Systematic Review.
Chan CWH; Tai D; Kwong S; Chow KM; Chan DNS; Law BMH
Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32344759
[TBL] [Abstract][Full Text] [Related]
19. Vascular effects of aromatase inhibitors: data from clinical trials.
Howell A; Cuzick J
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):143-9. PubMed ID: 15936188
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer treatment and cognitive function: the current state of evidence, underlying mechanisms and potential treatments.
Vodermaier A
Womens Health (Lond); 2009 Sep; 5(5):503-16. PubMed ID: 19702450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
